Guidelines for the diagnosis and management of hereditary spherocytosis.
Hereditary spherocytosis (HS) is a heterogeneous group of disorders with regard to clinical severity, protein defects and mode of inheritance. It is relatively common in Caucasian populations; most affected individuals have mild or only moderate haemolysis. There is usually a family history, and a typical clinical and laboratory picture so that the diagnosis is often easily made without additional laboratory tests. Atypical cases may require measurement of erythrocyte membrane proteins to clarify the nature of the membrane disorder and in the absence of a family history, occasionally molecular genetic analysis will help to determine whether inheritance is recessive or non-dominant. It is particularly important to rule out stomatocytosis where splenectomy is contraindicated because of the thrombotic risk. Mild HS can be managed without folate supplements and does not require splenectomy. Moderately and severely affected individuals are likely to benefit from splenectomy, which should be performed after the age of 6 years and with appropriate counselling about the infection risk. In all cases careful dialogue between doctor, patient and the family is essential. Laparoscopic surgery, when performed by experienced surgeons, can result in a shorter hospital stay and less pain.
Bolton-Maggs
P H B
PH
Manchester Royal Infirmary, Manchester, UK.
Stevens
R F
RF
Dodd
N J
NJ
Lamont
G
G
Tittensor
P
P
King
M-J
MJ
D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D008403:Mass Screening / Q000379:methods; D013103:Spherocytosis, Hereditary / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D013156:Splenectomy / Q000379:methods
D005492:Folic Acid